Drug and pharmaceutical recalls
17747 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IITrimix Inj 4.25ml Form MDV Penile Injection, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IITrimix Inj 30:3:5 MDV, 10ml Penile Injection, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IITrimix Inj 30:1:40 MDV, 5 ml Penile Injection, 30 and 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IITrimix Inj 30:1:20 MDV: 5 ml, 10 ml, 2x5 ml Penile Injection, 30 and 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IITrimix Inj 30:1:10 MDV, 5 ml Penile Injection, 30 and 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIPGE-1 Inj 40mcg/ml MDV, 5 ml Penile Injection, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIPGE-1 Inj 30mcg/ml MDV, 7 ml Penile Injection, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIPGE-1 Inj 20mcg/ml MDV: 5ml, 7ml, 10ml, 20ml Penile Injection, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIPGE-1 Inj 10mcg/ml MDV, 5ml Penile Injection, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIPapaverine Inj 30mg/ml Syr, 5mlsyr, 10mlsyr,10x0.95mlsyr Penile Injection, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIBimix Inj 30:1 MDV: 5ml, 10 ml, 3x10ml, 2x10ml Penile Injection, 30 and 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIBimix Inj 30:0.5 MDV, 5 ml syr Penile Injection, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIBimix Inj 30 :1 Syr, 12x1.5 ml syr, 10x1.2 ml syr, 2x2 ml syr, 2x1 ml syr, 12x.05 ml syr Penile Injection,30 and 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-05-29FDA-DrugMylan Institutional, Inc. (d.b.a. UDL Laboratories)Class IIIBudesonide Capsules, 3 mg, Enteric Coated, packaged in 30-count capsules unit dose (3 x 10 capsules blister packaged) per box, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505; Packaged and Distributed by: UDL Laboratories, Inc., Rockford, IL 61103, NDC 51079-020-03.
Failed Dissolution Specifications: Routine stability testing at the 12-month interval yielded an out-of-specification (OOS) result for dissolution testing.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILevothroid (levothyroxine sodium tablets, USP), 200 mcg, RX only, 100 tablets per bottle. Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1327-01
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILevothroid (levothyroxine sodium tablets, USP), 175 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1326-01
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILevothroid (levothyroxine sodium tablets, USP), 150 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1325-01.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILevothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1331-01.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILevothroid (levothyroxine sodium tablets, USP) , 125 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1324-01
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILevothroid (levothyroxine sodium tablets, USP), 112 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1330-01
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILevothroid (levothyroxine sodium tablets, USP), 100 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1323-01
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILloyd Thyro-Tab 0.200 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILloyd Thyro-Tab 0.175 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILloyd Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILloyd Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILloyd Thyro-Tab 0.100 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILloyd Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
- 2013-05-29FDA-DrugLloyd Inc. of IowaClass IILevothroid (levothyroxine sodium tablets, USP), 88 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1329-01
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief